In a cancer treatment breakthrough 20 years in the making, University of Pennsylvania (US) researchers have shown sustained remissions of up to a year among a small group of advanced chronic lymphocytic leukemia (CLL) patients treated with genetically engineered versions of their own T cells

Continue reading…

A gene therapy called NLX-P101 dramatically reduces movement impairment in Parkinson's patients.

Continue reading…

With the number of individuals with Parkinson's disease in 15 of the world's largest nations projected to double over the next generation, scientists engage the latest biotech innovations to uncover new routes for therapy and treatment.

Continue reading…

For brain disease patients of the future, the delivery of stem cell therapy may be as simple as a quick sniff. William Frey, an adjunct professor of pharmaceutics and University of Minnesota researcher in collaboration with principal investigator Lusine Danielyan of the University Hospital of Tuebingen, Germany and his colleagues have shown that when stem are suspended in a fluid and snorted, they travel rapidly to the brain and arrive intact. Continue reading…

Researchers from the Harvard Medical School have developed a new automated multiplex technology that will enable biotech labs to engineer entire pathways and genomes at an unprecedented rate, catapulting cell programming to a whole new level. Continue reading…

Physicians from Jewish Hospital conducted the first adult cardiac stem cell procedure on a 66-year-old man, who, as a result of congestive heart failure, had permanent scarring on his heart muscle. Continue reading…

Week of July 13, 2009

William H. Andrews, PhD

Dr. Andrews leads the scientific research and development function of Sierra Sciences. His team is now pursuing direct molecular approaches to temporarily activate telomerase expression, and is performing high‐throughput screening and drug discovery efforts.

While Director of Molecular Biology at Geron Corporation, he was one of the principal discoverers of the telomerase genes. He was awarded 2nd place as "National Inventor of the Year" in 1997 for this work, with his name appearing on numerous related patents and publications. He earned his Ph.D. in Molecular and Population Genetics at the University of Georgia. He has more than 25 refereed publications and abstracts.

At the upcoming Anti-Aging Conference: Clinical Applications for In-Office Procedures in San Jose, California (September 9-12, 2009), Dr. Andrews will present, Telomerase Activation: The Future of Anti‐Aging Medicine, on Friday, September 11th.

For more information call the A4M today; 1-888-997-0112. Continue reading…

Dr Zannos Grekos MD delivers a presentation in Washington DC about stem cell research. Stem cells are being used for the regeneration of tissue and organs. He highlights the advantages and disadvantages of each type of stem cell, from embryonic to cord, to adult stem cells. The basic features of stem cells are that they are able to self renew and also differentiate into effecter cells. This means that they can be educated to regenerate the specific organ that needs treatment.

To view the video, click here.

Dr. Greekos will be speaking at the upcoming A4M World Stem Cell Clinical Summit to be held in conjunction with the Anti-Aging Conference: Clinical Appliations for In-Office Procedures in San Jose, California, September 9-12, 2009. His presentation, Clinical Applications of Stem cells in Orthopedic Practices will explore the current uses of peripheral blood as well as bone marrow aspirate for patients with degenerative arthritic conditions with emphasis on joints. For more information, call 1-888-997-0112. Continue reading…

Week of June 15, 2009

Dipnarine Maharaj, MD

Dr. Dipnarine Maharaj is the Medical Director and founder of the South Florida Bone Marrow/Stem Cell Transplant Institute, one of the few completely outpatient bone marrow/stem cell transplant facilities in the country. He was also involved in the establishment of bone marrow/ stem cell transplant programs at the University of Miami and for other communities in Florida. He has been involved with clinical research studies using stem cells in the areas of cardiac regeneration, neurodegenerative diseases, and cancer treatments. Most recently, he has secured an Investigator-initiated IND from the FDA to study a novel treatment of solid tumors using only healthy white blood cells. His innovative approach to medicine has earned him international recognition.

At the upcoming A4M WORLD STEM CELL CLINICAL SUMMIT, to be held in conjunction with theAnti-Aging Conference: Clinical Applications for In-Office Procedures in San Jose, California (September 9-12, 2009), Dr. Maharaj will present, Stem Cells and Bone Marrow Transplants: Current Medical Applications and Clinical Studies in Regenerative Medicine, on Saturday, September 12th.

For more information, call 1-888-997-0112. Continue reading…

Zannos G. Grekos, MD speaks about Ischemic Cardiomyopathy Patients and Stem Cell Therapy at the 16th Annual Congress on Anti-Aging and Regenerative Medicine in Las Vegas, Nevada. Preview his discussion of the use of stem cells for regeneration of tissues and organs, repair of defective cell types and delivery of genetic therapies and chemo-therapeutic agents into the desired tissue. To view the video preview, click here.

Dr. Grekos will present "Stem Cells: Basic Concepts Current Clinical Applications and Case Studies" at the upcoming Anti-Aging Conference: Clinical Applications for In-Office Procedures in San Jose, California, September 9-12 2009. For more information, call 1-888-997-0112. Continue reading…